Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ANO3PROTEIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ANO3 is highly expressed in the brain, particularly in the cerebellum, basal ganglia (striatum, globus pallidus), thalamus, and cortical regions. This distribution aligns with its role in motor control and coordination.
No AI portrait yet
| Gene Symbol | ANO3PROTEIN |
| Function | is a member of the anoctamin family of calcium-activated chloride channels (CaCC). |
| Primary Expression | the brain, particularly in the cerebellum, basal ganglia (striatum, globus pallidus), thalamus, and cortical regions |
| Subcellular Localization | </span><span class="infobox-value">Plasma membrane, Cytoplasm, Endoplasmic reticulum</span></div> |
| Amino Acids | 913 aa |
| GeneCards | ANO3PROTEIN |
| Human Protein Atlas | ANO3PROTEIN |
| Transmembrane Architecture | 10 transmembrane helices with a reentrant pore loop between TM3 and TM4, a topology shared with other TMEM16 family members |
| Calcium Sensitivity | Intracellular calcium binding through multiple sites in the N-terminal and loop regions |
| Dimerization | Functional channels require dimerization, with each monomer contributing to the conducting pore |
| Phosphorylation | Multiple serine/threonine phosphorylation sites modulate channel activity |
| Cl- Equilibrium | At resting potentials, ANO3 activation depolarizes neurons toward the Cl- reversal potential (approximately -70 mV in many neurons) |
| Excitability Tuning | By modulating Cl- conductance, ANO3 influences action potential threshold and firing patterns |
| Shunting Inhibition | Increased Cl- conductance can reduce excitatory input effectiveness through shunting |
| Activity-Dependent Activation | Neuronal activity increases intracellular Ca2+, directly activating ANO3 |
| Associated Diseases | Als, Alzheimer, dementia, neurodegeneration |
| Interactions | RBFOX1 |
| KG Connections | 19 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
ANO3PROTEIN["ANO3PROTEIN"]
neurodegeneration["neurodegeneration"]
ANO3PROTEIN -->|"implicated_in"| neurodegeneration
style ANO3PROTEIN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ANO3PROTEIN in their description or question text
No additional research found